{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T18:59:11Z","timestamp":1770490751779,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.bmcl.2020.127521","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T11:29:30Z","timestamp":1598873370000},"page":"127521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Tricyclic sulfones as potent, selective and efficacious ROR\u03b3t inverse agonists \u2013 Exploring C6 and C8 SAR using late-stage functionalization"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0125-729X","authenticated-orcid":false,"given":"Qing","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zili","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Marcoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Cherney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiuhang","family":"Yip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dauh-Rurng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn A.","family":"Weigelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Sack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javed","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Ruzanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Yarde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Ellen Cvijic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sha","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Shuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"Sherry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Obermeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aberra","family":"Fura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Stefanski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia","family":"Cornelius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvi","family":"Chacko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue-Zhong","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Purnima","family":"Khandelwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"John","family":"Hynes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph A.","family":"Tino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Salter-Cid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rex","family":"Denton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qihong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.G. Murali","family":"Dhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2020.127521_h0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/mi.2016.86","article-title":"ROR\u03b3t, a multitask nuclear receptor at mucosal surfaces","volume":"10","author":"Eberl","year":"2017","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.bmcl.2020.127521_h0010","doi-asserted-by":"crossref","DOI":"10.11131\/2015\/101185","article-title":"Retinoic acid-related orphan receptors (RORs): regulatory functions in immunity, development, circadian rhythm, and metabolism","volume":"2","author":"Cook","year":"2015","journal-title":"Nucl Receptor Res"},{"key":"10.1016\/j.bmcl.2020.127521_h0015","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.immuni.2016.04.007","article-title":"A progenitor cell expressing transcription factor ROR\u03b3t generates all human innate lymphoid cell uubsets","volume":"44","author":"Scoville","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.bmcl.2020.127521_h0020","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1101\/sqb.2015.80.027615","article-title":"Regulation of ROR\u03b3t in inflammatory lymphoid cell differentiation","volume":"80","author":"Huang","year":"2015","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"10.1016\/j.bmcl.2020.127521_h0025","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.immuni.2014.04.005","article-title":"The emerging landscape of ROR\u03b3t biology","volume":"40","author":"Lee","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.bmcl.2020.127521_h0030","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s40257-018-0366-5","article-title":"Targeting the IL-23\/IL-17 pathway in psoriasis: the search for the good, the bad and the ugly","volume":"19","author":"Mylle","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.bmcl.2020.127521_h0035","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri3707","article-title":"IL-23-IL-17 immune axis: discovery, mechanistic understanding, and clinical testing","volume":"14","author":"Gaffen","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bmcl.2020.127521_h0040","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.3389\/fimmu.2018.01323","article-title":"The interleukin-23\/Interleukin-17 axis links adaptive and innate immunity in psoriasis","volume":"9","author":"Sch\u00f6n","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.bmcl.2020.127521_h0045","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.3390\/ijms20143394","article-title":"Th17 cells and the IL-23\/IL-17 axis in the pathogenesis of periodontitis and immune-mediated inflammatory diseases","volume":"20","author":"Bunte","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmcl.2020.127521_h0050","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41435-019-0067-y","article-title":"The IL-23\/IL-17 pathway in human chronic inflammatory diseases \u2013 new insight from genetics and targeted therapies","volume":"20","author":"Bianchi","year":"2019","journal-title":"Genes Immun"},{"key":"10.1016\/j.bmcl.2020.127521_h0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrd4518","article-title":"Targeting the IL-17\u2013TH17 pathway","volume":"14","author":"Bartlett","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmcl.2020.127521_h0060","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.immuni.2016.04.007","article-title":"A progenitor cell expressing transcription factor ROR\u03b3t generates all human innate lymphoid cell subsets","volume":"44","author":"Scoville","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.bmcl.2020.127521_h0065","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1101\/sqb.2015.80.027615","article-title":"Regulation of ROR\u03b3t in inflammatory lymphoid cell differentiation","volume":"80","author":"Huang","year":"2015","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"10.1016\/j.bmcl.2020.127521_h0070","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.tips.2014.07.006","article-title":"Targeting Th17 cells in autoimmune diseases","volume":"35","author":"Yang","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bmcl.2020.127521_h0075","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.4049\/jimmunol.1800013","article-title":"Discovery of the IL-23\/IL-17 signaling pathway and the treatment of psoriasis","volume":"201","author":"Hawkes","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/j.bmcl.2020.127521_h0080","first-page":"169","article-title":"Targeting the nuclear hormone receptor RORgt for the treatment of autoimmune and inflammatory disorders","volume":"48","author":"Dhar","year":"2013","journal-title":"Annu Rep Med Chem"},{"key":"10.1016\/j.bmcl.2020.127521_h0085","doi-asserted-by":"crossref","first-page":"37977","DOI":"10.1038\/srep37977","article-title":"Pharmacologic modulation of RORct translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis","volume":"6","author":"Xue","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmcl.2020.127521_h0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jdermsci.2016.10.001","article-title":"Oral administration of a novel ROR\u03b3t antagonist attenuates psoriasis-like skin lesion of two independent mouse models through neutralization of IL-17","volume":"85","author":"Takaishi","year":"2017","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.bmcl.2020.127521_h0095","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/13543776.2019.1655541","article-title":"Retinoic acid receptor-related orphan receptor gamma-t (ROR\u03b3t) inhibitors in clinical development for the treatment of autoimmune diseases: a patent review (2016-present)","volume":"29","author":"Sun","year":"2019","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.bmcl.2020.127521_h0100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/13543776.2017.1236918","article-title":"ROR\u03b3 antagonists and inverse agonists: a patent review","volume":"27","author":"Bronner","year":"2017","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.bmcl.2020.127521_h0105","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1080\/13543784.2016.1237502","article-title":"A review of emerging IL-17 inhibitors in the treatment of psoriasis focusing on preclinical through phase II studies","volume":"25","author":"Campa","year":"2016","journal-title":"Expert Opin Inv Drugs"},{"key":"10.1016\/j.bmcl.2020.127521_b0030","doi-asserted-by":"crossref","first-page":"9931","DOI":"10.1021\/acs.jmedchem.9b01369","article-title":"Rationally designed, conformationally constrained inverse agonists of ROR\u03b3t \u2014 identification of a potent, selective series with biologic-like in vivo efficacy","volume":"62","author":"Marcoux","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2020.127521_b0035","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1021\/acsmedchemlett.0c00063","article-title":"Discovery of BMS-986251: a potent and selective ROR\u03b3t inverse agonist selected as a clinical candidate","volume":"11","author":"Cherney","year":"2020","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmcl.2020.127521_b0040","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1021\/acsmedchemlett.9b00010","article-title":"Structure-based discovery of phenyl (3-Phenylpyrrolidin-3-yl)sulfones as selective, orally active ROR\u03b3t inverse agonists","volume":"10","author":"Duan","year":"2019","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmcl.2020.127521_h0125","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1080\/17460441.2019.1653850","article-title":"An overview of late-stage functionalization in today's drug discovery","volume":"14","author":"Moir","year":"2019","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.bmcl.2020.127521_h0130","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1039\/C5CS00628G","article-title":"The medicinal chemist\u2019s toolbox for late stage functionalization of drug-like molecules","volume":"45","author":"Cernak","year":"2016","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.bmcl.2020.127521_b0050","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1021\/jo070477u","article-title":"Bromination of deactivated aromatics: a simple and efficient method","volume":"72","author":"Rajesh","year":"2007","journal-title":"J Org Chem"},{"key":"#cr-split#-10.1016\/j.bmcl.2020.127521_b0055.1","unstructured":"(a) Zhuang, L. Discovery of VTP-43742, a ROR\u03b3t inverse agonist for the treatment of psoriasis. 13th Winter Conference on Medicinal and Bioorganic Chemistry, Steamboat Springs, CO, Jan 22-26, 2017"},{"key":"#cr-split#-10.1016\/j.bmcl.2020.127521_b0055.2","doi-asserted-by":"crossref","unstructured":"(b) Gege, C. ROR\u03b3t inhibitors as potential back-ups for the phase II candidate VTP-43742 from Vitae Pharmaceuticals: patent evaluation of WO2016061160 and US20160122345. Expert Opin Ther Pat 2017, 27, 1\u22128.","DOI":"10.1080\/13543776.2017.1262350"},{"key":"10.1016\/j.bmcl.2020.127521_h0145","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1021\/tx060234h","article-title":"Prediction of in vivo potential for metabolic activation of drugs into chemically reactive intermediate: correlation of in vitro and in vivo generation of reactive intermediates and in vitro glutathione conjugate formation in rats and humans","volume":"20","author":"Masubuchi","year":"2007","journal-title":"Chem Res Toxicol"},{"issue":"7","key":"10.1016\/j.bmcl.2020.127521_h0150","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1021\/acs.chemrestox.0c00081","article-title":"Structure-based reactivity profiles of reactive metabolites with glutathione","volume":"33","author":"Liu","year":"2020","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.bmcl.2020.127521_b0065","unstructured":"see supporting information of ref. 8 for protocols of the IL-23 induced mouse acanthosis study."},{"key":"10.1016\/j.bmcl.2020.127521_h0160","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.4049\/jimmunol.1001001","article-title":"IL-23\u2013mediated psoriasis-like epidermal hyperplasia is dependent on IL-17A","volume":"186","author":"Rizzo","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.bmcl.2020.127521_h0165","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature05505","article-title":"Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2020.127521_h0170","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1084\/jem.20060244","article-title":"IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2\u2212dependent mechanisms with implications for psoriasis pathogenesis","volume":"203","author":"Chan","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.bmcl.2020.127521_b0075","unstructured":"Dhar, T. G. M.; Xiao, Z.; Yang, M. Tricyclic sulfone compound as a ROR gamma modulator. WO 2019\/222438 A1."},{"key":"10.1016\/j.bmcl.2020.127521_b0080","unstructured":"Fox, B. X.; Furukawa, N.; Hao, X. et al. Fused bicyclic nitrogen-containing heterocycles. WO 2004\/047755 A2, June 10, 2004."}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X20306326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X20306326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:36:51Z","timestamp":1760773011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X20306326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":37,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0960894X20306326"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2020.127521","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tricyclic sulfones as potent, selective and efficacious ROR\u03b3t inverse agonists \u2013 Exploring C6 and C8 SAR using late-stage functionalization","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2020.127521","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"127521"}}